26
Views
44
CrossRef citations to date
0
Altmetric
Journal Article

Aluminum and bone disorders: with specific reference to aluminum contamination of infant nutrients.

&
Pages 199-214 | Published online: 27 Aug 2013

References

  • AndersonWA, HaupinWE: Aluminum and aluminum alloys. In GraysonM, EckrothD (eds): “Kirk—Othmer Encyclopedia of Chemical Technology.” New York: Wiley, pp 129–188, 1978.
  • HarrisSA: Soluble aluminum in plants and soils. Nature 189: 513–514, 1961.
  • FoyCD, ChaneyRL, WhiteMC: The physiology of metal toxicity in plants. Annu Rev Plant Physiol 29: 511–566, 1978.
  • KingSW, SavoryJ, WillsMR: The clinical biochemistry of aluminum. CRC Crit Rev Clin Lab Sci 14: 1–20, 1981.
  • AlfreyAC: Aluminum. Adv Clin Chem 23: 69–91, 1983.
  • SkalskyH, CarchmanR: Aluminum homeostasis in man. J Am Coll Toxicol 2: 405–423, 1983.
  • KruegerGL, MorrisTK, SuskindRR, WidnerEM: The health effect of aluminum compounds in mammals. CRC Crit Rev Toxicol 13: 1–24, 1984.
  • MorrisTK, KruegerGL: The ecological effects of aluminum complexes in freshwater fish and their environments. In BhumralkarCH (ed): “Meteorological aspects of acid rain. Vol 1.” Boston: Butterworth, pp 231–239, 1984.
  • KoopJF: Occurrence of trace element in water. Trace Subst Environ Health 3: 59–73, 1969.
  • WardMK, FeestTG, EllisHA, ParkinsonIS, KerrDNS: Osteomalacic dialysis osteodystrophy: evidence for a water-borne etiological agent, probably aluminum. Lancet 1: 841–845, 1978.
  • ParkinsonIS, WardMK, FeestTG, FawcettRWP, KerrDNS: Fracturing dialysis osteodystrophy and dialysis encephalopathy: an epidemiological survey. Lancet 1: 406–409, 1979.
  • JonesJ: Center for Food Safety and Applied Nutrition, Division of Chemical Technology, Washington, DC (personal communication).
  • GorskyJE, DietzAA, SpencerH, OsesD: Metabolic balance of aluminum studied in six men. Clin Chem 25: 1739–1743, 1979.
  • GregerJL, BaierMJ: Excretion and retention of low or moderate levels of aluminum by human subjects. Food Chem Toxic 21: 473–477, 1983.
  • TennakoneK, WickramanayakeS: Aluminum leaching from cooking utensils. Nature 324: 202, 1987.
  • ClarksonEM, LuckVA, HynsonWV, BaileyRR, EastwoodJB, WoodheadJS, ClementsVR, O'RiordanJLH, DeWardenerHE: The effect of aluminum hydroxide on calcium, phosphorus and aluminum balances, the serum parathyroid hormone concentrations and the aluminum content of bone in patients with chronic renal failure. Clin Sci 43: 519–531, 1972.
  • CamJM, LuckVA, EastwoodJB, DeWardenerHE: The effect of aluminum hydroxide orally on calcium, phosphorus, and aluminum in normal subjects. Clin Sci Mol Med 51: 407–414, 1976.
  • ReckerRR, BlotchyAJ, LefflerJA, RackEP: Evidence for aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. J Lab Clin Med 90: 810–815, 1977.
  • KaehnyWD, HeggAP, AlfreyAC: Gastrointestinal absorption of aluminum from aluminum containing antacids. N Engl J Med 296: 1389–1390, 1977.
  • SlaninaP, FrechW, BernhardsonA, CedergrenA, MattssonP: Influence of dietary factors on aluminum absorption and retention in the brain and bone of rats. Acta Pharmacol Toxicol 56: 331–336, 1985.
  • SlaninaP, FrechW, EkstromL, LoofL, SlorachS, CedergrenA: Dietary citric acid enhances absorption of aluminum in antacids. Clin Chem 32: 539–541, 1986.
  • MartinRB: The chemistry of aluminum as related to biology and medicine. Clin Chem 32: 1797–1806, 1986.
  • Burnatowska-HledinMA, DoyleTM, EadieMJ, MayorGH: 1,25 dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats. J Lab Clin Med 108: 96–102, 1986.
  • MayorGH, SpragueSM, HouraniMR, SanchezTV: Parathyroid hormone-mediated aluminum deposition and egress in the rat. Kidney Int 17: 40–44, 1980.
  • StoneCJ, McLaurinDA, SteinhagenWH, CavenderFL, HasemanJK: Tissue deposition patterns after chronic inhalation exposures of rats and guinea pigs to aluminum chlorhydrate. Toxicol Appl Pharmacol 49: 71–76, 1979.
  • MussiI, CalzaferriG, BurattiM, AlessioL: Behaviour of plasma and urinary aluminum levels in occupationally exposed subjects. Int Arch Occup Environ Health 54: 155–161, 1984.
  • AlfreyAC, HeggA, CraswellP: Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr 33: 1509–1516, 1980.
  • KleinGL, OttSM, AlfreyAC, SherrardDJ, HazletTK, MillerNL, MaloneyNA, BerquistWE, AmentME, CoburnJW: Aluminum as a factor in the bone disease of long-term parenteral nutrition. Trans Assoc Am Physcians 95: 155–164, 1982.
  • OttSM, MaloneyNA, KleinGL, AlfreyAC, AmentME, CoburnJW, SherrardDJ: Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Ann Intern Med 98: 910–914, 1983.
  • SedmanAB, KleinGL, MerrittRJ, MillerNL, WeberKO, GillWL, AnandH, AlfreyAC: Evidence of aluminum loading in infants receiving intravenous therapy. N Engl J Med 312: 1337–1343, 1985.
  • KooWWK, KaplanLA, BendonR, SuccopP, TsangRC, HornJ, SteichenJJ: Response to aluminum in parenteral nutrition during infancy. J Pediatr 109: 877–883, 1986.
  • KovalchikMT, KaehnyWD, HeggAP, JacksonJT, AlfreyAC: Aluminum kinetics during hemodialysis. J Lab Clin Med 92: 712–720, 1978.
  • RahmanH, SkillenAW, ChannonSM, WardMK, KerrDNS: Methods for studying the binding of aluminum by serum protein. Clin Chem 31: 1969–1973, 1985.
  • CochranM, PattersonD, NeohS, StevensB, MazzachiR: Binding of aluminum by protein in plasma of patients on maintenance hemodialysis. Clin Chem 31: 1314–1316, 1985.
  • KaehnyWD, AlfreyAC, HolmanRE, ShorrWJ: Aluminum transfer during hemodialysis. Kidney Int 12: 361–365, 1977.
  • AllainP, ThebaudHE, DupouetL, CovilleP, PisantM, SpiesserJ, AlquierP: Study of blood levels of a number of metals (Al, Mn, Cd, Pb, Cu, Zn) in chronic hemodialysis patients before and after dialysis. Nouv Presse Med 7: 92–96, 1978.
  • GacekEM, BabbAL, UvelliDA, FryDL, ScribnerBH: Dialysis dementia: The role of dialyzate pH in altering the dialyzability of aluminum. Trans Am Soc Artif Intern Organs 25: 409–415, 1979.
  • GiddenH, HollandFF, KleinE: Trace metal protein binding in normal and dialyzed uremic serum. Trans Am Soc Artif Intern Organs 26: 133–138, 1980.
  • GrafH, StummvollHK, MeisingerV, KovarikJ, WolfA, PinggeraWF: Aluminum removal by hemodialysis. Kidney Int 19: 587–592, 1981.
  • RottembourgJ, GallegoJL, JaudonMC, ClavelJP, LegrainM: Serum concentration and peritoneal transfer of aluminum by continuous ambulatory peritoneal dialysis. Kidney Int 25: 919–924, 1984.
  • HodsmanAB, HoodSA, BrownP, CordyPE: Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine? J Lab Clin Med 106: 674–681, 1985.
  • AndreoliSP, BergsteinJM, SherrardDJ: Aluminum intoxication from aluminum containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med 310: 1079–1084, 1984.
  • SedmanAB, MillerNL, WaradyBA, LumGM, AlfreyAC: Aluminum loading in children with chronic renal failure. Kidney Int 26: 201–204, 1984.
  • AlfreyAC, LeGendreG, KaehnyWD: The dialysis encephalopathy syndrome possible aluminum intoxication. N Engl J Med 294: 184–188, 1976.
  • KleinGL, BerquistWE, AmentME, CoburnJW, MillerNL, AlfreyAC: Hepatic aluminum accumulation in children on total parenteral nutrition. J Pediatr Gastroenterol Nutr 3: 740–743, 1984.
  • BuchetJP, LauwerysR, RoelsH, HubermontG: Mobilization of lead during pregnancy in rats. Occup Environ Health 40: 33–36, 1977.
  • KellerCA, DohertyRA: Bone lead mobilization in lactating mice and lead transfer to suckling offspring. Toxicol Applied Pharmacol 55: 220–228, 1980.
  • OttSM, MaloneyNA, CoburnJW, AlfreyAC, SherrardDJ: The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitrol therapy. N Engl J Med 307: 709–713, 1982.
  • FelsenfeldAJ, GutmanRA, LlachF, HarrelsonJM: Osteomalacia in chronic renal failure: a syndrome previously reported only with maintenance dialysis. Am J Nephrol 2: 147–154, 1982.
  • PetitTL: Aluminum in human dementia. Am J Kidney Dis 6: 313–316, 1985.
  • KatzmanR: Alzheimer's disease. N Engl J Med 314: 964–973, 1986.
  • O'HareJA, MurnaghanDJ: Reversal of aluminum induced hemodialysis anemia by a low aluminum dialysate. N Engl J Med 306: 654–656, 1982.
  • McLaughlinAIG, KazantzisG, KingE, TeareD, PorterRJ, OwenR: Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminum dust. Br J Indust Med 19: 253–263, 1962.
  • DentCE, WinterCS: Osteomalacia due to phosphate depletion from excessive aluminum hydroxide ingestion. Br Med J 1: 551–552, 1974.
  • FawcettHA, SmithNP: Injection site granuloma due to aluminum. Arch Dermatol 120: 1318–1322, 1984.
  • WilliamsS, FreemontAJ: Aerosol antiperspirants and axillary granulomata. Br Med J 288: 1651–1652, 1984.
  • FischerT, RystedtI: A case of contact sensitivity of aluminum. Contact Dermatitis 8: 343, 1982.
  • QuarlesLD, GitelmanHJ, DreznerMK: Aluminum associated bone disease: What's in a name? J Bone Min Res 2: 389–390, 1987.
  • HodsmanAB, SherrardDJ, WongEGC, BrickmanAS, LeeDBN, AlfreyAC, SingerFR, NormanAC, CoburnJW: Vitamin D resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. Ann Intern Med 94: 629–637, 1981.
  • BoyceBF, FellGS, ElderHY, JunorBJ, ElliotHL, BeastallG, FogelmanI, BoyleIT: Hypercalcemic osteomalacia due to aluminum toxicity. Lancet 2: 1009–1012, 1982.
  • Cournot-WitmerG, ZingraffJ, PlachotJJ, EscaigF, LefevreR, BoumatiP, BourdeauA, GarabedianM, GalleP, BoudonR, DruekeT, BalsanS: Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney Int 20: 375–385, 1981.
  • BrownDJ, DawbornJK, HamKN, XipellJM: Treatment of dialysis osteomalacia with desferrioxamine. Lancet 2: 343–345, 1982.
  • MallucheHH, SmithAJ, AbreoK, FaugereMC: The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure. N Engl J Med 311: 140–144, 1984.
  • FaugereMC, AmalaIO, RitzE, MallucheHH: Loss of bone resulting from accumulation of aluminum in bone of patients undergoing dialysis. J Lab Clin Med 107: 481–487, 1986.
  • RobertsonJA, FelsenfeldAJ, HaygoodCC, WilsonP, ClarkeC, LlachF: Animal model of aluminum induced osteomalacia: role of chronic renal failure. Kidney Int 23: 327–335, 1983.
  • ChanYL, AlfreyAC, PosenS, LissnerD, HillsE, DunstanCR, EvansRA: Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology. Calcif Tissue Int 35: 344–351, 1983.
  • GoodmanWG, GilliganJ, HorstR: Short term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia. J Clin Invest 73: 171–181, 1984.
  • GoodmanWG: Short-term aluminum administration in the rat. Reductions in bone formation without osteomalacia. J Lab Clin Med 103: 749–757, 1984.
  • CharhonSA, ChavassieuxPM, ChapuyMC, BoivinGY, MeunierPJ: Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminum intoxication. J Lab Clin Med 106: 123–131, 1985.
  • EllisHA, McCarthyJH, HerringtonJ: Bone aluminum in hemodialyzed patients and in rats injected with aluminum chloride: relationship to impaired bone mineralization. J Clin Pathol 32: 832–844, 1979.
  • GoodmanWG, HenryDA, HorstR, NudelmanRK, AlfreyAC, CoburnJW: Parenteral aluminum administration in the dog: II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney Int 25: 370–375, 1984.
  • BachraBN, Van HarskampGA: The effect of polyvalent metal ions on the stability of a buffer system for calcification in vitro. Calcif Tissue Res 4: 359–365, 1970.
  • BlumenthalNC, PosnerAS: In vitro model of aluminum-induced osteomalacia: inhibition of hydroxyapatite formation and growth. Calcif Tissue Int 36: 439–441, 1984.
  • SherrardDJ, OttS, MaloneyN, AndressD, CoburnJ: Uremic osteodystrophy: classification, cause and treatment. In FrameB, PottsJ (eds): “Clinical Disorders in Bone and Mineral Metabolism.” Amsterdam: Excerpta Medica, pp 254–258, 1983.
  • MeunierPJ, BressotC: Endocrine influences on bone cells and bone remodelling evaluated by clinical histomorphometry. In ParsonJA (ed): “Endocrinology of Calcium Metabolism.” New York: Raven, pp 445–465, 1982.
  • TeitelbaumSI, BergfieldMA, FreitagJ, HruskaKA, SlatopolskyE: Do parathyroid hormone and 1,25 dihydroxyvitamin D modulate bone formation in uremia? J Clin Endocrinol Metab 51: 247–251, 1980.
  • WeinsteinRS, UnderwoodJL, HutsonMS, DeLucaHF: Bone histomorphometry in vitamin D deficient rats infused with calcium and phosphorus. Am J Physiol 193: E499–E505, 1984.
  • KooWWK, TsangRC: Bone mineralization in infants. Prog Food Nutr Sci 8: 229–302, 1984.
  • HodsmanAB, SherrardDJ, AlfreyAC, OttSM, BrickmanAS, MillerNL, MaloneyNA, CoburnJW: Bone aluminum and histomorphometric features of renal osteodystrophy. J Clin Endocrinol Metab 54: 539–546, 1982.
  • AndressD, FelsenfeldA, VoightsA, LlachF: Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney Int 24: 364–370, 1983.
  • AndressDL, OttSM, MaloneyNA, SherrardDJ: Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. New Engl J Med 312: 468–473, 1985.
  • MorrisseyJ, RothsteinM, MayorG, SlatopolskyE: Suppression of parathyroid hormone secretion by aluminum. Kidney Int 23: 699–704, 1983.
  • HenryDA, GoodmanWG, NudelmanRK, DiDomenicoNC, AlfreyAC, SlatopolskyE, StanleyTM, CoburnJW: Parenteral aluminum administration in the dog: 1. Plasma kinetics, tissue levels, calcium metabolism, and parathyroid hormone. Kidney Int 25: 362–369, 1984.
  • SiegelN, HaugA: Aluminum interaction with calmodulin. Evidence for altered structure and function from optical and enzymatic studies. Biochim Biophys Acta 744: 36–45, 1983.
  • LieberherrM, GrosseB, Cournot WitmerG, ThilCL, BalsanS: In vitro effects of aluminum on bone phosphatases: a possible interaction with bPTH and vitamin D3 metabolites. Calcif Tissue Int 34: 280–284, 1982.
  • TrappGA: Studies of aluminum interaction with enzymes and proteins—the inhibition of hexokinase. Neurotoxicology 1: 89–100, 1980.
  • ViolaRE, MorrisonJF, ClelandWW: Interaction of metal (III) adenosine 5′ triphosphate complexes with yeast hexokinase. Biochemistry 19: 3131–3137, 1980.
  • OndreickaR, GinterE, KortusJ: Chronic toxicity of aluminum in rats and mice and its effect on phosphorus metabolism. Br J Ind Med 23: 305–312, 1966.
  • MossAH, SolomonCC, AlfreyAC: Elevated plasma adenine nucelotide levels in chronic renal failure and their possible significance. Proc Clin Dial Transplant Forum 9: 184–188, 1979.
  • SpencerH, KramerL: Osteoporosis: calcium, fluoride and aluminum interactions. J Am Coll Nutr 4: 121–128, 1985.
  • BakerLRI, AckrillP, CattellWR, StampTCB, WatsonL: Iatrogenic osteomalacia and myopathy due to phosphate depletion. Br Med J 3: 150–152, 1974.
  • RostyniakPJ: An electrothermal atomic absorption method for aluminum analysis in plasma: identification of sources of contamination in blood sampling procedures. J Anal Toxicol 7: 20–23, 1983.
  • BertholfRL, BrownS, RenoeBW, WillsMR, SavoryJ: Improved determination of aluminum in serum by electrothermal atomic absorption spectorphotometry. Clin Chem 29: 1087–1089, 1983.
  • Burnatowska-HledinM, MayorGH: Aluminum: analytical considerations. Am J Kidney Dis 6: 283–287, 1985.
  • WillsMR, BrownS, SavoryJ: Aluminum. In PesceAJ, KaplanLA (eds): “Clinical Chemistry: Methods of Analysis.” St Louis: Mosby, 1987.
  • FreundlichM, ZillerueloG, AbitbolC, StraussJ, FaugereMC, MallucheHH: Infant formula as a cause of aluminum toxicity in neonatal uremia. Lancet 2: 527–529, 1985.
  • KooWWK, TsangRC: Rickets in infants. In NelsonNM (ed): “Current Therapy in Neonatal Perinatal Medicine.” Philadelphia: Decker BC, p 299–304, 1985.
  • KooWWK, KaplanLA, HornJ, TsangRC, SteichenJJ: Aluminum in parenteral nutrition solution—sources and possible alternatives. J Parenteral Enteral Nutr 10: 591–595, 1986.
  • KleinGL, TargoffCM, AmentME, SherrardDJ, BluestoneR, YoungJH, NormanAW, CoburnJW: Bone disease associated with total parenteral nutrition. Lancet 2: 1041–1044, 1980.
  • KleinGL, HorstRL, NormanAW, AmentME, SlatoploskyE, CoburnJW: Reduced serum levels of 1,25 dihydroxyvitamin D during long term total parenteral nutrition. Ann Intern Med 94: 638–643, 1981.
  • ShikeM, HarrisonJE, SturtridgeWC, TamCS, BobechkoPE, JonesG, MurrayTM, JeejeebhoyKN: Metabolic bone disease in patients receiving long term total parenteral nutrition. Ann Intern Med 92: 343–350, 1980.
  • ShikeM, SturtridgeWC, TamCS, HarrisonJE, JonesG, MurrayTM, HusdanH, WhitwellJ, WilsonDR, JeejeebhoyKN: A possible role of vitamin D in the genesis of parenteral nutrition induced metabolic bone disease. Ann Intern Med 95: 560–568, 1981.
  • De VernejoulMC, MessingB, ModrowskiD, BielakoffJ, BuisineA, MiravetL: Multifactorial low remodeling bone disease during cyclic total parenteral nutrition. J Clin Endocrinol Metab 60: 109–113, 1985.
  • HeymanMB, KleinGL, WongA, ReckerRR, TyrrellJB, AlfreyAC, SherrardDJ, HohnDC: Aluminum does not accumulate in teenagers and adults on prolonged parenteral nutrition containing free amino acids. J Parenteral Enteral Nutr 10: 86–87, 1986.
  • BarryPSI, MossmanDB: Lead concentration in human tissues. Br J Ind Med 27: 339–351, 1970.
  • BarryPSI: Concentrations of lead in the tissues of children. Br J Ind Med 38: 61–71, 1981.
  • BarltropD: Transfer of lead to the human fetus. In BarltropD, BurlandWL (eds): “Mineral Metabolism in Pediatrics.” Philadelphia: Davis, pp 135–151, 1969.
  • McCarthyJT, KurtzSB, McCallJT: Elevated bone aluminum content in dialysis patients without osteomalacia. Mayo Clinic Proc 60: 315–320, 1985.
  • Van de VyverFL, VerbuekenAH, VisserWJ, Van GriekenRE, De BroeME: Localisation of aluminum and iron by histochemical and laser microprobe mass analytical techniques in bone marrow cells of chronic hemodialysis patients. J Clin Pathol 37: 837–838, 1984.
  • KooWWK, TsangRC, SteichenJJ, SuccopP, BabcockD, OestreichAE, NoseworthyJ, HornJ, FarrellMK: Parenteral nutrition for infants: effects of high versus low calcium and phosphorus content. J Pediatr Gastronenterol Nutr 6: 96–104, 1987.
  • WeintraubR, HamsG, MeerkinM, RosenbergAR: High aluminum content of infant formulas. Arch Dis Child 61: 914–916, 1986.
  • KooWWK, KaplanLA: Aluminum contamination of infant formulas. J Parenteral Enteral Nutr, 1988, to appear.
  • JakobssonI, LindbergT, BenediktssonB, HanssonBG: Dietary bovine B lactoglobulin is transferred to human milk. Acta Pediatr Scand 74: 342–345, 1985.
  • ZieglerEE, EdwardsBB, JensenRL, MahaffeyKR, FomonSJ: Absorption and retention of lead by infants. Pediatr Res 12: 29–34, 1978.
  • TrotterM, HixonBB: Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec 179: 1–18, 1974.
  • LudwigJ (ed): “Current Methods of Autopsy Practice,” 2nd ed. Philadelphia: Saunders, pp 665–666, 1979.
  • KooWWK, GuanZP, TsangRC, LaskarzewskiP, NeumannV: Growth failure and decreased bone mineral of newborn rats with chronic furosemide therapy. Pediatr Res 20: 74–78, 1986.
  • SpectorWS (ed): “Handbook of Biological Data,” The National Academy of Sciences and the National Research Council. Philadelphia: Saunders, p 73, 1961.
  • Reference 118, p 70.
  • LemireRJ, LoeserJD, LeechRW, AlvordEC (eds): “Normal and Abnormal Development of the Human Nervous System.” New York: Harper and Row, p 38, 1975.
  • SteichenJJ, TsangRC: Bone mineralization and growth in term infants prospectively fed soy based or cow milk based formula. J Pediatr, 110: 687–692, 1987.
  • KohlerL, MeeuwisseG, MortenssonW: Food intake and growth of infants between six and twenty six weeks of age on breast milk, cow's milk formula, or soy formula. Acta Pediatr Scand 73: 40–48, 1984.
  • ShenaiJP, JhaveriBM, ReynoldsJW, HustonRK, BabsonSG: Nutritional balance studies in very low birth weight infants. Role of soy formula. Pediatrics 67: 631–637, 1981.
  • CallenbachJC, SheehanMB, AbramsonSJ, HallRT: Etiologic factors in rickets of very low birth weight infants. J Pediatr 98: 800–805, 1981.
  • ShenaiJP, ReynoldsJW, BabsonSG: Nutritional balance studies in very low birth weight infants: enhanced nutrient retention rates by an experimental formula. Pediatrics 66: 233–238, 1980.
  • SteichenJJ, TsangRC, GreerFR HoM, HugG: Elevated serum 1,25(OH)2 vitamin D concentrations in rickets of very low birth weight infants. J Pediatr 99: 293–298, 1981.
  • KooWWK, OestreichA, TsangRC, ShermanR, SteichenJ: Natural history of rickets and fractures in very low birth weight infants during infancy. J Bone Min Res 1: 123, 1986.
  • MillinerDS, ShinabergerJH, ShumanP, CoburnJW: Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. N Engl J Med 312: 165–167, 1985.
  • SedmanAB, AlfreyAC, MillerNL, GoodmanWG: Tissue and cellular basis for impaired bone formation in aluminum related osteomalacia in the pig. J Clin Invest 79: 86–92, 1987.
  • SpectorWS (ed): “Handbook of Biological Data,” The National Academy of Sciences and the National Research Council. Philadelphia: Saunders, pp 159–161, 1961.
  • AltmanPL, DittmerDS: “Growth including Reproduction and Morphological Development,” Technical Documentary Report NO AMRL-TDR 63-2. Washington, DC: The Committee on Biological Handbooks, Federation of American Societies for Experimental Biology. pp 333–378, 1963.
  • SwartzRD: Deferoxamine and aluminum removal. Am J Kidney Dis 6: 358–364, 1985.
  • OlivieriNF, BuncicJR, ChewE, GallantT, HarrisonRV, KeenanN, LoganW, MitchellD, RicciG, SkarfB, TaylorM, FreedmanMH: Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med 314: 869–873, 1986.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.